Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fluoroquinolone Resistance Prevalence Study
Sponsor: Hackensack Meridian Health
Summary
This is an exploratory study to determine the prevalence of fluoroquinolone resistance in patients receiving dose-intense melphalan with autologous peripheral blood stem cell (PBSC) transplantation in the treatment of multiple myeloma (MM). These data may be used in subsequent studies exploring the use of prophylaxis in this patient population.
Official title: Exploratory Study of Fluoroquinolone Resistance for Patients Undergoing Autologous Hematopoietic Stem Cell (HSC) Transplantation in the Treatment of Multiple Myeloma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
124
Start Date
2022-07-08
Completion Date
2025-01-15
Last Updated
2026-06-05
Healthy Volunteers
No
Conditions
Locations (2)
Lombardi Comprehensive Cancer Center, Georgetown University
Washington D.C., District of Columbia, United States
John Theurer Cancer Center, Hackensack Meridian Health
Hackensack, New Jersey, United States